Penserra Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$43.82 - $85.37 $38,298 - $74,613
-874 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$33.21 - $51.27 $29,025 - $44,809
874 New
874 $37,000
Q3 2019

Nov 15, 2019
SELL
$26.26 - $34.86 $783,677 - $1.04 Million
-29,843 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$17.43 - $28.82 $520,163 - $860,075
29,843 New
29,843 $790,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
92.3M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email